Abstract:Background: Comorbidity of mental disorders hampers diagnosis and treatment of mental disorders which leaves the heavier disease burden, but little is known about its prevalence and contributing factors in China among general population. Method: China Mental Health Survey (CMHS), a cross-sectional epidemiological face-to-face household survey, was organized by Peking University Sixth Hospital in cooperation with 43 institutes across 31 provinces in China, from July 2013 to March 2015. The trained lay interviewers conducted the computer assisted personal interview of the Composite International Diagnostic (CIDI) diagnosed by The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) covering 26 mental disorders, assembled into four mental disorder classes - mood disorders class, anxiety disorders class, impulse control disorders class, substance use disorders class. The number of respondents above 18 years old completed the CIDI was 28,140 with response rate 72·90%, conforming to the valid sample size estimation. The weighted data base on post-stratification adjustment weights, non-response adjustment weight and sampling design weights. Main outcome measures include the lifetime and 12-month epidemiological comorbidity of mental disorders in China, namely their prevalence, correlation and potential contributing factors.Findings: The weighted epidemiological comorbidity prevalence of mental disorders was 4·62% (95% CI 4·38-4·88) for lifetime, and 2·42% (95% CI 2·24-2·60) for the past 12 months among Chinese general population. One quarter of those participants suffering mental disorder had at least one other comorbid mental disorder across whole life, and 22% for 12-month prevalence by the weighted estimation. For the comorbidity of specific mental disorders class, the impulse control disorders class took striking place reaching 76·38% (95% CI 72·31-80·45) with the weighted lifetime prevalence and the weighted 12- month prevalence 65·30% (95% CI 59·93-70·67); Mood disorders class comorbid with anxiety disorders class was the most common combination. We found strongly positive correlation between substance use disorders class and mood disorders class, as well as substance use disorders class and anxiety disorders class. The risk factors of mental disorders class comorbidity involved age > 50, alcohol use and chronic disease; and potential protective factors included married, working status, and higher educational level.Interpretation: Among general population in China, Comorbidity of mental disorders class is common as expected, in need of more medical resources to address it. The mechanism of mental disorders comorbidity needs further investigation to drive precise diagnosis and better treatment outcome hinted by correlations and potential contributing factors of mental disorders comorbidity. Popularizing the knowledge of mental disorders comorbidity among general population is more beneficial to its prevention, thereby relieve the public's disease burden.Funding Information: The study was funded by the special research project for non-profit public service of the Chinese Ministry of Health (grant number 201202022), the national twelfth five-year plan for science and technology support of the Chinese Ministry of Science and Technology (grant numbers 2012BAI01B01 & 2015BAI13B00) and the National Key R&D Program of China (grant numbers 2017YFC0907800 and 2017YFC0907801).Declaration of Interests: All authors declare no competing interests.Ethics Approval Statement: CMHS was approved by the Ethical Committee of the Sixth Hospital of Peking University (IMHIRB2013–13–1). All procedures involving human participants were in accordance with the ethical standards of the institutional or national research committee and with the 1964 Helsinki declaration and its later amendments or similar ethical standards. Written informed consent was obtained from all participants for data use.

The National Comorbidity Survey of the United States

The Prevalence and Correlates of Nonaffective Psychosis in the National Comorbidity Survey Replication (NCS-R)

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services

The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: A family history study

Mental and Substance Use Disorders Prevalence Study: Background and Methods

Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study

The cross-national structure of mental disorders: results from the World Mental Health Surveys.

Exploring Comorbidity Within Mental Disorders Among a Danish National Population

Epidemiological Comorbidity of Mental Disorders in China: Data Analysis and Implication

WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders.

Prevalence, comorbidity, disability and service utilisation

Criminal Victimization and Comorbid Substance Use and Psychiatric Disorders in the United States: Results from the NESARC

Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample

Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)

A pilot study of new approaches to exploring illness trajectories and patterns of comorbidity in major mental disorders

Long-term effects of mental disorders on educational attainment in the National Comorbidity Survey ten-year follow-up

Cross-national epidemiology of DSM-IV major depressive episode

Twelve-month Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in Metropolitan China.

Latent Classes of Comorbid Substance Use and Internalizing and Externalizing Symptoms and Their Stability in U.S. Adults Over Time: Findings from the PATH Study Waves 1–3 (2013–2016)